ImmuCell Announces Strong Preliminary, Unaudited Sales Results for Second Quarter of 2021

PORTLAND, Maine, July 07, 2021 (GLOBE NEWSWIRE) — ImmuCell Corporation (Nasdaq: ICCC) (ImmuCell or the Company), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health…

Click here to view the original article.